GlassScriptPhysician profile
John Kolton Smith
NPI 1376120725
$873.98
in general payments reported to CMS, 2019-2025
11 companies · $537 in 2025
The $537 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $337 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $703 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $703.04 |
| Education | $170.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $393.29 | 2024-2025 | Zynyz, Jakafi, Monjuvi |
| E.R. Squibb & Sons, L.L.C. | $132.87 | 2024 | |
| Merck Sharp & Dohme LLC | $97.60 | 2024-2025 | Keytruda, Welireg |
| Geron Corporation | $48.82 | 2025 | Rytelo |
| Exelixis INC. | $46.06 | 2025 | Cabometyx |
| Jazz Pharmaceuticals INC. | $32.37 | 2025 | |
| Blueprint Medicines Corporation | $28.91 | 2024 | Ayvakit |
| Bayer Healthcare Pharmaceuticals INC. | $24.97 | 2024 | |
| Syndax Pharmaceuticals, INC. | $24.35 | 2025 | |
| Janssen Biotech, INC. | $23.00 | 2025 | Talvey, Tecvayli, Darzalex |
| Regeneron Healthcare Solutions, INC. | $21.74 | 2025 | Libtayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.